The Respiratory and Lung Research group has ongoing research in both basic and clinical science. A key aim is to translate the group’s findings from the laboratory to patients, as well as taking patient problems to inform laboratory-based research. The group welcome both basic scientists and clinicians with an interest in lung disease to work in the group.

Laboratory research projects

  1. TGF-Beta laboratory studies using in vitro and murine studies.
  2. Effects of steroids in asthma/ chronic obstructive pulmonary disease (COPD). These studies examine new treatments for asthma/ COPD in mouse models.
  3. Human metapneumovirus (hMPV) studies in vitro. This is an important new virus and these studies examine its activity in asthma and COPD models.
  4. Extracellular traps in health and disease (with A/Prof Paul King).

Clinical research projects

  1. COPD studies focus on exacerbations, diagnostic imaging, cardiac morbidities, new treatments and rehabilitation.
  2. Asthma studies evaluate severe asthma, vocal cord dysfunction and new treatments.
  3. Lung infection studies are focused on disease mechanisms in bronchiectasis, cystic fibrosis, COPD and pneumonia.
+ Read more

Diseases we research

Research Group Head | Professor Philip Bardin

Obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) affect more than a third of all Australians. Acute flares, caused by virus infections, often result in disability and sometimes death. My research aims to prevent this by enhancing immunity and designing new treatments.
Professor Philip Bardin

Student opportunities

Publication highlights

Our research group is keen to discuss funding opportunities

Support our research